Does Recombinant Human Bone Morphogenic Protein 2 Affect Perioperative Blood Loss after Lumbar and Thoracic Spinal Fusion?
Nathan Wanderman, Bayard Carlson, William Robinson, Mohamad Bydon, Michael Yaszemski, Paul Huddleston, Brett Freedman
Asian Spine J. 2018;12(5):880-886.   Published online 2018 Sep 10     DOI: https://doi.org/10.31616/asj.2018.12.5.880
Citations to this article as recorded by Crossref logo
Lumbar Interbody Fusion using Low-dose of Recombinant Human Bone Morphogenetic Protein-2 (rh-BMP2); Minimum 1-year Follow-up Results at A Single Institute
Sang-soo Choi, Wo-Jung Lim, Min-Ki Lee, Kyeong-Sik Ryu
Journal of Minimally Invasive Spine Surgery and Technique.2021; 6(1): 2.     CrossRef
Growth factor delivery: Defining the next generation platforms for tissue engineering
Lilith M. Caballero Aguilar, Saimon M. Silva, Simon E. Moulton
Journal of Controlled Release.2019; 306: 40.     CrossRef